-
Healthcare
-

Prescription Alerts and the Quiet Work of NHS Digital Reform

By
Distlled Post Editorial Team

Rob Thompson, chief digital data and technology officer at NHS England

A patient in her seventies walks to the pharmacy for the second time that week. The first trip ended with a polite suggestion to come back after lunch. The second ends the same way, because the queue is long and the dispensing is not finished. Nobody has been negligent. The pharmacist is working flat out, the patient has done what was asked, and the only thing missing is a signal that passes between them. That signal is now arriving. Patients in England can receive a notification on their phone or smartwatch the moment their medication is ready for collection.

The scale is already meaningful. The service is live in roughly 2,500 community pharmacies, about one in three in England, and covers major chains including Boots and Asda. Patients must switch on push notifications in the NHS App to receive alerts. The feature extends the prescription tracking tool introduced last year, which has been used by nearly 2.9 million people and opened more than nine million times. Those figures describe a habit forming, which matters more than any single launch.

The significance lies in what the alert removes. Every wasted journey is a small cost to the patient, and every speculative phone call is a small cost to a pharmacy team. Multiplied across millions of prescriptions, these costs are a real drain on a sector that the government expects to carry more of the system's weight. Community pharmacy is being asked to take on clinical services, relieve general practice and keep people out of hospital. It cannot do that while staff spend part of each day answering whether an order is ready. A notification handles the question before it is asked.

The feature also illustrates a wider point about how reform works in practice. Large strategies tend to be judged by their headline ambitions, such as a single front door to the health service or patients holding their own records. Those ambitions are credible only if the app does ordinary, useful things reliably. People who find that it tells them when their medicines are ready are more likely to return for appointments, test results and referrals. Trust in digital services is built in small transactions long before it is asked to support anything weightier. Giving patients direct sight of their own information, in a form they can act on, is how that trust accumulates.

The picture across the border is instructive, and not only for contrast. Audit Wales has reported that Welsh health boards retain clear digital ambitions, but that progress is slowed by constrained capital budgets, ageing infrastructure and difficulty recruiting specialist staff. None of this is unique to Wales. Similar pressures exist in English trusts. What England has is a national platform with the central funding and engineering capacity to build once and deploy widely. Devolution gives Wales the freedom to design its own path, yet the same freedom means it carries the cost of building capability that England can share across a much larger population. The practical opportunity is closer cooperation on standards, shared components and lessons learned, so that patients on either side of the border are not left with a very different quality of service.

For NHS leaders, the implication is to treat adoption as an operational metric alongside waiting times. Uptake of notifications, and the fall in avoidable pharmacy contacts they should produce, can be measured, and the results should inform where limited improvement effort goes next. For pharmacy owners, reliability is everything, because an alert sent before a prescription is truly ready will undo the goodwill the feature creates. For health-tech suppliers, interoperability with dispensing systems is the commercial prize and the practical test. Policymakers should note that an opt-in design depends on patients being able to find and trust the setting, which makes plain communication part of delivery.

A buzz on the wrist is a small thing, and that is rather the point. The health service rarely changes through one decisive intervention. It changes when many small frictions are removed by systems that work, at a scale only a national organisation can reach. England has shown that the approach is feasible. The next test is whether the whole of Britain can share in it.